NEW YORK (GenomeWeb News) — BioTrove and Agilent Technologies will co-market an Agilent mass spectrometer with BioTrove’s sample-preparation systems, the companies said yesterday.

 

Specifically, the firms will co-market Agilent’s 6410 triple quadrupole mass spec with BioTrove’s RapidFire high-throughput sample-prep systems.

 

BioTrove said the RF-MS will be used to screen in high-throughput “previously intractable drug targets, cytochrome P450 inhibition, and other pre-clinical ADME assays."